(S)-(-)-[HC]nicotine binding assessed by PET: A dual tracer model evaluated in the rhesus monkey brain

Alzheimer Disease and Associated Disorders

Volumn 12, Issue 3, 1998, Pages 238-246

  Lundqvist, Hans ^a   Nordberg, Agneta ^b   Hartvig, Per ^c   Långström, Bengt ^d  

^a Department of Biomédical Radiation Sciences ^*  (Sweden)

^b Hospital Pharmacy   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Flowpet ; Nicotine binding ; Receptor (s) ( ) c nicotine regional cerebral blood; Rhesus monkey

Indexed keywords

CARBON; NICOTINE; NICOTINIC RECEPTOR; OXYGEN;

ANIMAL; ARTICLE; BLOOD FLOW; BRAIN; BRAIN MAPPING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; HUMAN; MACACA; METABOLISM; PHYSIOLOGY; REFERENCE VALUE; SCINTISCANNING; VASCULARIZATION;

ANIMALS; BRAIN; BRAIN MAPPING; CARBON RADIOISOTOPES; FEMALE; HUMANS; MACACA MULATTA; NICOTINE; OXYGEN RADIOISOTOPES; RECEPTORS, NICOTINIC; REFERENCE VALUES; REGIONAL BLOOD FLOW; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032153561     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-199809000-00018     Document Type: Article

References (31)

1. Copeland JR, Adem A, Jacob III P, Nordberg A. A comparison of the binding of nicotine and nornicotine stereoisomers to nicotinic binding sites in rat brain cortex. Naunyn-Schmiedeberg Arch Pharmacol 1991;343:123-7.
2. Grünwald F, Biersack H-J, Kuschinsky W. Nicotine receptor mapping. EtirJNitclMed 1996;23:1012-3.
3. Hall M, Zerbe L, Leonard S, Freedman R. Characterization of (!H)cytisine binding to human brain membrane preparations. Brain Res 1993;600:127-33.
4. Halldin C, Nâgren K, S wähn C-G, Langström B, Nybäck H. (S)- and (R)(1 lC)-nicotine and the metabolite (R/S)-(1 lC)cotinine. Preparation, metabolite studies and in vivo distribution in the human brain using PET. NitclMedBiol 1992;19:871-80.
5. Kämpfer I, Sorger D, Schliebs R, et al. Radioiodination of nicotine with specific activity high enough for mapping nicotinic acetylcholine receptors. EtirJNucl Med 1996;23:157-62.
6. Konishi J, Magata Y, Yonekura Y, et al. Studies on the effects of smoking on cerebral perfusion and metabolism: basic studies with in vivo tracer methods. Jpn J Psychophannacol 1993; 13:167-74.
7. Larsson C, Nordberg A. Comparative analysis of nicotine-like receptor-ligand interaction in rodent brain horhogenate. JNeiuvcliein 1985;45:24-31.
8. Lippiello PM, Fernandes KG. The hinging of L- H-nicotine to a single class of high affinity sites in rat brain membranes. Mol Pharmacol 1986;29:448-54.
9. Mazière M, Delforge J. PET imaging of (1 l-C)nicotine: historical aspects. In: Domino EF, ed. Brain imaging of nicotine and tobacco smoking. Ann Arbor: NPP Books, 1995:13-28.
10. McGehee DS, Role LW. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Anna Rev Physio! 1995; 57:52116.
11. Nordberg A. A comparison of the (S)(-) and (R)(+) enantiomers of nicotine with respect to pharmacological and behavioural effects and receptor binding properties in experimental animals and man. Med Chem Res 1993;2:522-9.
12. Nordberg A. Human nicotinic receptors-their role in aging and dementia. Neiirochem Int 1994;25:93-7.
13. Nordberg A, Adem A, Hardy J, Winblad B. Changes in nicotinic receptor subtypes in temporal cortex of Alzheimer brains. Neurosci Lett 1988:86:317-21.
14. Nordberg A, Alafuzoff I, Winblad B. Nicotinic and muscarinic receptor subtypes in the human brain: changes with ageing and dementia. J Neurosci Res 1992;31:103-11.
15. Nordberg A, Hartvig P, Lundqvist H, Antonit G, Ulin J, Langström B. Uptake and regional distribution of (+)-(R) and (-)-(S)-N-[methylC-l l]-nicotine in the brain of rhesus monkey: an attempt to study nico-
16. tinic receptors in vivo. J Neural Transm 1989; 1:195-205.
17. Nordberg A, Hartvig P, Lilja A, et al. Decreased uptake and binding of C-l 1-nicotine in brain of Alzheimer patients as visualized by positron emission tomography. J Neural Transm 1990;2:21524.
18. Nordberg A, Lilja A, Lundqvist H, et al. Tacrine restores cholinergic nicotinic receptors and glucose metabolism in Alzheimer patients as visualized by positron emission tomography. NeurobiolAging 1992;13: 74758.
19. Nordberg A, Lundqvist H, Hartvig P, et al. Imaging of nicotinic and muscarinic receptors in Alzheimer's disease: effect of tacrine treatment. Dementia Geriatr Cogn Disord 1997;8:7884.
20. Nordberg A, Lundqvist H, Hartvig P, Lilja A, Lângstrom B. Kinetic analysis of regional (S)(-)llCnicotine binding in normal and Alzheimer brains-in vivo assessment using positron emission tomography. Alzheimer Dis Assoc Disord 1995;9:217.
21. Nordberg A, Winblad B. Reduced number of 3H-nicotine and 3H-acetylcholine binding sites in the frontal cortex of Alzheimer brains. Neurosci Lett 1986;72:115-9.
22. Nybäck H, Halldin C, Ahlin A, Curvall M, Eriksson L. PET studies of the uptake of (S)- and (R)-(l lC)nicotine in the human brain: difficulties in visualizing specific receptor binding in vivo. Psychopharmacology 1994;! 15:31-6.
23. Nybäck H, Nordberg A, Lângstrsm B, et al. Attempts to visualize nicotinic receptors in the brain of monkey and man by positron emission tomography. Prog Brain Res 1989;79:313-9.
24. Oldendorf VH. Lipid solubility and drug penetration of the blood brain barrier. Five Soc Exp Biol Med 1974; 147:813-6.
25. Perry E, Perry R, Smith C, et al. Nicotinic receptor abnormalities in Alzheimer's and Parkinson's disease. JNeurosurg Psychiatr 1987;50: 806-9.
26. Rubboli F, Cours J, Sala C, et al. Distribution of nicotinic receptors in the human hippocampus and thalamus. Eur J Neitrosci 1994;6: 1569-604.
27. Sargent PB. The diversity of neuronal nicotinic acetylcholine receptors. Anmi Rev Neurosci 1993;16:40313.
28. Sorger D, Kämpfer I, Knapp WH. Letter to the editor. Reply. EurJNiid Med 1996;23:1013.
29. Warpman U, Nordberg A. Epibatidine and ABT 418 reveal selective losses of a4ß2 nicotinic receptors in Alzheimer brains. NeuroReport 1995;6:241923.
30. Whitehouse P, Martino A, Lowenstein P, Coyle J, Price D, Kellar K. Nicotinic acetylcholine binding sites in Alzheimer's disease. Brain Res 1986;371:14651.
31. Yokoi F, KomiyamaT, ItoT, HayashiT, lio M, HaraT. Application of carbonl 1 labelled nicotine in the measurement of human cerebral blood flow and other physiological parameters. Eur J Nitcl Med 1993; 20:4652.